JangoBio: Next Generation Hormone Replacement Therapy
JangoBio: Next Generation Hormone Replacement Therapy “Stem cell therapies have the potential to restore hormone balance and reverse the symptoms of menopause and andropause without the negative side-effects associated with current pharmaceutical-based hormone therapies. This personalized medicine approach is a long-term fix that will enable individuals to live healthier lives, longer.” Craig S. Atwood, Ph.D., […]
Yes we can cure and prevent cardiovascular disease – and you can help!
Yes we can cure and prevent cardiovascular disease – and you can help! – CVD is the #1 killer in the world today. Dr. J.B. Tunac and Arterez were recently invited to publish their remarkable findings in the US based Cardiology and Cardiovascular Research journal. Below is the journal abstract: Gene deficient or knockout (KO) […]
Soligenix, Inc. – A rare disease company with multiple near-term and potentially transformational catalysts
Soligenix, Inc. – A rare disease company with multiple near-term and potentially transformational catalysts Drug development takes many years, but Soligenix has arrived in 2020 while remaining under the radar of many investors Soligenix (Nasdaq: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an […]
Introduction to The SoulPhysio Foundation
Introduction to The SoulPhysio Foundation The SoulPhysio Foundation is a nonprofit organization based in Orange County, CA. Their mission is to combat Mental and Neurological Illness in children by helping educate parents and faculty in schools about the importance of brain health. Mental Illness including ADHD, Autism, Depression, and Anxiety are on the rise at […]
REVANCE THERAPEUTICS: THE PRESTIGE MEDICAL AESTHETIC BIOTECH
REVANCE THERAPEUTICS: THE PRESTIGE MEDICAL AESTHETIC BIOTECH Revance is a Silicon Valley-based biotechnology company daring to make a difference by focusing on innovative aesthetic and therapeutic offerings, featuring its next-generation investigational neuromodulator product, DaxibotulinumtoxinA for Injection (DAXI). The company is progressing a portfolio of products and service across aesthetic medicine and underserved therapeutic specialties, including […]
Client Spotlight: PYC Therapeutics
Client Spotlight: PYC Therapeutics PYC Therapeutics is part of the ‘precision medicine’ revolution targeting rare genetic diseases. The company combines world-class expertise in RNA drug design with propriety intracellular delivery technology to develop highly precise and safe medicines. Company highlights include: Proven RNA expertise – PYC’s Chief of R&D has co-invented two FDA approved drugs […]
Innovative Medicine Partners LLC — Innovators in the Field of ObGyn/Infertility
Our world renown team of innovators in the field of ObGyn/Infertility has groundbreaking research that supports new clinical procedures and devices that will change lives struggling with infertility. These two innovations represent a $1.5 billion + potential annual revenue stream. Innovative Medicine Partners LLC is a dynamic and collaborative network of medical visionaries working together […]
OXIO Health, Inc. – Impacting Healthcare Transformation
OXIO Health, Inc. – Impacting Healthcare Transformation OXIO Health, Inc.® (OXIO®) has been carefully developed and designed to produce a material impact on the U.S. healthcare delivery system, by achieving significant reductions in healthcare cost, while driving an increase in quality of care and patient access to care. Today, healthcare remains the largest single global […]
Client Spotlight – Akamara Therapeutics, Inc.
Client Spotlight – Akamara Therapeutics, Inc. Akamara Therapeutics is a private immunotherapy company seeking to change the way people live by developing innovative B cell therapeutics. Akamara is well positioned to capitalize on important emerging science supporting B cell activation as a therapeutic approach in human cancer. Despite positive impact on survival by approved immuno-oncology […]
Vaccine Expert Joins Geneius’s Coronavirus Program
Vaccine Expert Joins Geneius’s Coronavirus Program Geneius Biotechnology, Inc., a developmental stage biotechnology company pioneering natural T cell therapeutics for medical conditions associated with viruses and cancer and prevention of virus infections, announces that Wolfgang Klietmann, M.D., FCAP, is joining the company to advise on its coronavirus program. Dr. Klietmann is a Clinical Pathologist and […]